Physician
Internal Medicine
Dr. James Y. Miller, MD
|
|
Give Review
James Y. Miller works in the field of Internal Medicine. He studied medicine at Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine is ranked 8/29 in Research/PrimaryCare. He over the years received 1 awards: "Elected Member". Dr. James Y. Miller is a published doctor and has 101 publications published. The lastest was: 'Urinary bombesin-like peptide levels in infants and children with bronchopulmonary dysplasia and cystic fibrosis.'
Publications
- Validation of a multiprotein plasma classifier to identify benign lung nodules.
- Application of SNP microarrays to the Genome-wide Analysis of Chromosomal Instability in Premalignant Airway Lesions.
- Lung cancer chemoprevention: current status and future prospects.
- Neprilysin regulates Pulmonary artery smooth muscle cell phenotype through a platelet-derived growth factor receptor-dependent mechanism.
- Endobronchial miRNAs as Biomarkers in Lung Cancer Chemoprevention.
- Non-invasive Breath Analysis of Pulmonary Nodules.
- Alveolar Hypoxia Promotes Murine Lung Tumor Growth Through a VEGFR-2/EGFR Dependent Mechanism.
- Progressive Endobronchial Premalignancy: Marked by Original CIN.
- Oral iloprost improves endobronchial dysplasia in former smokers.
- Lung Cancer Diagnosis from Proteomic Analysis of Preinvasive Lesions.
- Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk.
- Decreased neprilysin and Pulmonary vascular remodeling in chronic obstructive Pulmonary disease.
- Vascular endothelial growth factor receptor 2-targeted chemoprevention of murine lung tumors.
- Does unilateral DIPNECH provide clues to pathogenesis?
- The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence.
- Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
- Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development.
- A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.
- Neprilysin null mice develop exaggerated Pulmonary vascular remodeling in response to chronic hypoxia.
- Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: an international, multicenter clinical trial.
- Overexpression of Sprouty 2 in mouse lung epithelium inhibits urethane-induced tumorigenesis.
- Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer.
- Bronchioloalveolar carcinoma presenting as chronic progressive Pulmonary infiltrates in a woman with HIV: a diagnosis worth making.
- Minimizing unintended consequences of detecting lung nodules by computed tomography.
- Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer.
- Sputum cytologic atypia predicts incident lung cancer: defining latency and histologic specificity.
- Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive Pulmonary disease.
- Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer.
- Inhaled corticosteroids and lung cancer chemoprevention.
- Lack of association between sputum atypia and chronic obstructive Pulmonary disease mortality.
- Update in lung cancer 2005.
- Stridor in a 47-year-old man with inflammatory bowel disease.
- Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung c...
- Proteomic patterns of preinvasive bronchial lesions.
- Role of rho in the increased migration of Pulmonary artery smooth muscle cells observed in the neprilysin knockout mouse.
- Pathogenesis of lung cancer: 100 year report.
- Lung cancer: genetics of risk and advances in chemoprevention.
- Interstitial lung disease, lung cancer, lung transplantation, Pulmonary vascular disorders, and sleep-disordered breathing in AJRCCM in 2004.
- Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.
- Sprouty 2 gene in mouse lung tumorigenesis.
- High prevalence of endobronchial malignancy in high-risk patients with moderate dysplasia in sputum.
- Airway antioxidants and oxidative stress as predictors of sputum atypia and airflow obstruction.
- Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction.
- Bombesin-like peptides and mast cell responses: relevance to bronchoPulmonary dysplasia?
- Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hy...
- Genetic susceptibility to lung cancer.
- Randomized controlled trial with low-dose spiral CT for lung cancer screening: feasibility study and preliminary results.
- Manipulation of Pulmonary prostacyclin synthase expression prevents murine lung cancer.
- High prevalence of occult endobronchial malignancy in high risk patients with moderate sputum atypia.
- Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer.
- Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis.
- Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections.
- Mycobacterium tuberculosis presenting as an infected Pulmonary bulla.
- gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth.
- Screening for lung cancer revisited and the role of sputum cytology and fluorescence bronchoscopy in a high-risk group.
- Correlative assessment of morphologic, immunophenotypic, and genetic changes in bronchial epithelium of tobacco smokers.
- Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
- p172: An alveolar type II and Clara cell specific protein with late developmental expression and upregulation by hyperoxic lung injury.
- Expansion of bronchial epithelial cell populations by in vitro culture of explants from dysplastic and histologically normal sites.
- Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories.
- Low or absent peptidase expression in plexiform lesions of primary Pulmonary hypertension.
- Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo.
- Carboxypeptidase M. Variable expression in normal human lung and inactivation in lung cancer.
- Low neutral endopeptidase levels in bronchoalveolar lavage fluid of lung cancer patients.
- Surfactant protein C promoter-driven expression of T1-alpha induces lung inflammation.
- Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related diseases.
- Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy.
- Inactivation of neutral endopeptidase in lung cancer.
- Mutational inactivation of aminoacylase-I in a small cell lung cancer cell line.
- Brief report: idiopathic diffuse hyperplasia of Pulmonary neuroendocrine cells and airways disease.
- Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.
- Human aminoacylase-1. Cloning, sequence, and expression analysis of a chromosome 3p21 gene inactivated in small cell lung cancer.
- 2A3 and 3F9. Novel lung epithelial antigens with early upregulation in hyperoxic and radiation lung injury models.
- High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of Pulmonary neuroendocrine cells.
- Novel bombesin-like peptide binding proteins from lung.
- Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort.
- Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers.
- Lack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3p.
- Neuroendocrine differentiation, neuropeptides, and neprilysin.
- Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.
- Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study.
- Tumour necrosis factor gene polymorphisms are associated with COPD.
- Bombesin-like peptides: from frog skin to human lung.
- Small cell lung cancer: etiology, biology, clinical features, staging, and treatment.
- Increased Pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma.
- Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
- Hemorrhage and resuscitation alter the expression of ICAM-1 and P-selectin in mice.
- Molecular events in lung carcinogenesis.
- Monoclonal antibodies specific for antigens expressed by rat type II alveolar epithelial and nonciliated bronchiolar cells.
- Urinary bombesin-like peptide levels in infants and children with bronchoPulmonary dysplasia and cystic fibrosis.
- A 2.5-Mb physical map within 3p21.1 spans the breakpoint associated with Greig cephalopolysyndactyly syndrome.
- Pulmonary neuroendocrine cells and lung development: dim outlines emerge.
- Isolation of the bombesin/gastrin-releasing peptide receptor from human small cell lung carcinoma NCI-H345 cells.
- Staging of non-small-cell lung cancer with positron-emission tomography.
- Chronic Pulmonary emboli. Sparing of affected regions of lung from noncardiogenic Pulmonary edema.
- Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells.
- The Pulmonary neuroendocrine cell: a role in adult lung disease?
- Evaluation of subjective oral health status indicators.
- Human aminoacylase-1: cloning, regional assignment to distal chromosome 3p21.1, and identification of a cross-hybridizing sequence on chromosome 18.
- Monoclonal antibodies to human transferrin: epitopic and phylogenetic analysis.
Schools
Duke University
Barnes Jewish Hospital
University Colo Health Scis Center
Conditions Treated
- Pulmonary Hypertension
- Sleep Apnea
Doctors Specialties
- Pulmonology
- Internal Medicine
Accepted Insurances
Awards
- Elected Member
Education
-
University of Colorado -
Washington University - Barnes-Jewish Hospital -
Duke University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Thomas H. Soper, DO
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard C. Lamb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James A. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marvin Lee II, MD
This Doctor is OpenDoctor Recommended.
|